The use of age-specific reference ranges for serum prostate specific antigen in men 60 years old or older.
about
The Present and Future of Biomarkers in Prostate Cancer: Proteomics, Genomics, and Immunology AdvancementsAssessing follow-up care after prostate-specific antigen elevation in American Indian / Alaska Native Men: a partnership approachThe value of screening tests for detection of prostate cancer in 1000 saudi menPatterns of clinical response to PSA elevation in American Indian/Alaska Native men: a multi-center pilot study.Unraveling Brazilian Indian population prostate good health: clinical, anthropometric and genetic features.An alternative method for Frailty Index cut-off points to define frailty categories.Biomarkers for prostate cancer detection.Prostate biopsy in Central Europe: results of a survey of indication, patient preparation and biopsy technique.Serum concentrations of prostate-specific antigen after diagnostic procedures and transurethral microwave thermotherapy of benign prostatic hyperplasia.Evaluation of prostate-specific antigen, digital rectal examination and transrectal ultrasonography in population-based screening for prostate cancer: improving the efficiency of early detection.Prostate carcinoma screening in the county of Tyrol, Austria: experience and results.Predictors for biopsy outcome in the European Randomized Study of Screening for Prostate Cancer (Rotterdam region).Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.Relationship among age, prostate-specific antigen, and prostate volume in men with lower urinary tract symptoms (LUTS) and in different groups of men with and without benign and malignant prostate diseases.
P2860
Q26750672-42187C38-FA91-4C68-A40D-E3E255706736Q36056426-A3D8674A-53FD-423B-ABC5-C9FEECC971CCQ36133950-D5293CAD-2243-41D6-B965-61CF2EEAFF1EQ36522807-9894AE03-B82E-4BD7-A15A-705F38108558Q36575833-B4F57C69-8D8C-4FA7-95BA-EC849F14420FQ37416230-31B3AC13-998C-4888-BD1A-D6B52755889CQ37656233-B68BE0F4-3398-485E-BFB6-19CDF973AB0DQ39213076-1B82BC08-7459-4A93-AE6F-C50798471543Q39427967-D24B796E-D7CE-433A-8084-A2B183F5BB85Q39444092-5C797B0A-0E2A-4484-B763-4ACB5EFB4B80Q39455198-B42A9752-3DF4-4724-9CE8-6D996DB2C8ACQ39509015-BE350B2D-7D02-443D-9A8C-16B9DF272830Q39710858-045C85AC-0477-4627-8E04-548DE8245634Q47893970-313A2126-8408-4DBE-875E-EB752D102B66
P2860
The use of age-specific reference ranges for serum prostate specific antigen in men 60 years old or older.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
The use of age-specific refere ...... in men 60 years old or older.
@en
The use of age-specific refere ...... in men 60 years old or older.
@nl
type
label
The use of age-specific refere ...... in men 60 years old or older.
@en
The use of age-specific refere ...... in men 60 years old or older.
@nl
prefLabel
The use of age-specific refere ...... in men 60 years old or older.
@en
The use of age-specific refere ...... in men 60 years old or older.
@nl
P1476
The use of age-specific refere ...... in men 60 years old or older.
@en
P2093
J E Oesterling
W H Cooner
P304
P356
10.1016/S0022-5347(01)67538-4
P407
P577
1995-04-01T00:00:00Z